Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Standard vs Low Dose Albumin in SBP
NCT02756741Completed
- Sponsor
- AIIMS New Delhi
- Start
- Apr 2014
- Primary completion
- Jul 2015
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Randomised, open-label trial of albumin (human) in spontaneous bacterial peritonitis (SBP) (2 arms), sponsored by AIIMS New Delhi. Primary endpoints: Change in neutrophils/mm in ascitic fluid at 3 days and Change in IL-6, IL-1, TNF in ascitic fluid and serum at 5 days. Started Apr 2014; status: completed.
02
Drugs
albumin (human)
03
Conditions
spontaneous bacterial peritonitis (SBP)
Beyond the preview
Go deeper on NCT02756741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02756741.